Abstract
The management of hepatocellular carcinoma (HCC) is evolving with use of immunotherapies, stereotactic ablative, and selective internal radiotherapy treatments. The relative position of these treatments to each other and to...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.